Delivery Order SPE2DB20D1100-SPE2DB25FE1EG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,322.67, with a completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 100 mg tablets (60-count units) valued at $2,048.51. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of VIMPAT 150 mg tablets (60 count) valued at $1,013.36. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.40 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in a 200 ml volume. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200 ml quantities, with a ceiling value of $1,048.32. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, awarded on September 3, 2025. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The award has a potential value of $1,487.60 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1EGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,689.20 to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count supply). This competitive, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed-price terms. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare procurement. As a primary pharmaceutical supplier through the DLA Medical Supply Chain, the company distributes an extensive portfolio of medications and medical supplies, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. VIMPAT (lacosamide) is an antiepileptic medication commonly used in military and veteran healthcare systems. The DLA Troop Support Medical contract enables AmerisourceBergen to supply pharmaceutical products globally to support Defense Health Agency operations and other federal healthcare systems, with plans underway for the agency to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts involving several contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/25/25 |